Discussing axSpA: Long-term safety and efficacy of bimekizumab and ixekizumab in r-axSpA
The IMID Forum
- Published
- July 16, 2026
- Duration
- 23:48
- Summary source
- description
- Last updated
- Aug 5, 2026
Discusses Join Dr Sofia Ramiro and Professor Atul Deodhar as they discuss the top publications in the world of…
Summary
Join Dr Sofia Ramiro and Professor Atul Deodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered the long-term safety and efficacy of bimekizumab and ixekizumab in r-axSpA.
Intelligent Report
Sign in to read teasers, or upgrade to Research Pro to commission intelligent report for this episode. Learn more →
Show notes
Join Dr Sofia Ramiro and Professor Atul Deodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered the long-term safety and efficacy of bimekizumab and ixekizumab in r-axSpA.